Short answer · Medically reviewed summary · Last updated: 2026-04-06
Treatment for Mastocytosis and Mast Cell Activation Syndrome (MCAS) is primarily focused on stabilizing mast cells and managing the symptoms caused by the release of inflammatory mediators. First-Line Pharmacological Treatments The cornerstone of managing Mastocytosis and MCAS involves a combination of H1 and H2 antihistamines to block the receptors that respond to histamine. Commonly prescribed H1 blockers include cetirizine (Zyrtec) or fexofenadine (Allegra), while H2 blockers include famotidine (Pepcid).
4 people with Mastocytosis and MCAS have shared their first-person experience on this question at DiseaseMaps.
What are the best treatments for Mastocytosis and MCAS?
Treatments for Mastocytosis and MCAS: what real patients say works for them, alongside a medically reviewed overview citing sources like NIH GARD and Orphanet.
Treatment for Mastocytosis and Mast Cell Activation Syndrome (MCAS) is primarily focused on stabilizing mast cells and managing the symptoms caused by the release of inflammatory mediators.
First-Line Pharmacological Treatments
The cornerstone of managing Mastocytosis and MCAS involves a combination of H1 and H2 antihistamines to block the receptors that respond to histamine. Commonly prescribed H1 blockers include cetirizine (Zyrtec) or fexofenadine (Allegra), while H2 blockers include famotidine (Pepcid). Many patients also utilize mast cell stabilizers like cromolyn sodium (Gastrocrom) to reduce intestinal symptoms and leukotriene inhibitors like montelukast (Singulair) to address respiratory or systemic reactions. Patients are frequently advised to carry an epinephrine auto-injector (EpiPen, Auvi-Q) for emergency management of anaphylaxis.
Non-Pharmacological and Lifestyle Management
Non-pharmacological management is essential for long-term stability. Patients often work with dietitians to identify and avoid specific dietary triggers, which vary significantly between individuals. Reducing physical and emotional stress is critical, as these are common triggers for mast cell degranulation. While there is no "surgery" for Mastocytosis, some patients require procedures to manage complications like osteoporosis or gastrointestinal issues.
Multidisciplinary Care and Personalization
Treatment effectiveness is highly individualized; what helps one patient may be ineffective for another. Because Mastocytosis and MCAS are systemic conditions, a multidisciplinary care team is vital. This team typically includes an immunologist or allergist, a hematologist, a gastroenterologist, and a dermatologist. Regular monitoring is necessary to adjust medications based on the patient's specific symptom profile and laboratory markers.
Emerging Research
Research into targeted therapies, such as tyrosine kinase inhibitors (e.g., avapritinib), is evolving rapidly, particularly for advanced forms of Mastocytosis. Clinical trials continue to explore novel biologics and monoclonal antibodies aimed at further suppressing mast cell activation.
Disclaimer: This information is for educational purposes only and does not constitute medical advice. All treatment plans must be developed and monitored by your personal healthcare team, as dosages and medication choices depend on your specific clinical history and disease subtype.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Mastocytosis
- Orphanet: Rare Disease Database (Mastocytosis)
- The Mast Cell Disease Society (TMS)
In my medicine toolbox:
EPI Pen
IUD Birth Control for the Cardiac Symptoms
1 - Allegra/Day
1 - 2 - Zantac/Day
1 - Baby Aspirin
1 - Albuterol Rescue Inhaler
1 - Steroid Inhaler
Benadryl for emergencies
Posted May 20, 2017 by Teepee80 500
Posted Sep 30, 2017 by Meredith 2000
Posted Jan 19, 2018 by Melissa Ashby 1020
Doing Ranitidine, cromolyn dissodico, singulair, ebastina, supplement calcium and vit D and medication sos polaramine and prednisolone.
Posted Mar 3, 2017 by elsa oliveira 1000
